Boehringer Korea to expand investment for global clinical studies

Published: 2005-08-22 06:57:00

Updated: 2005-08-22 06:57:00

Under the company motto "Value through innovation" and its action guideline "Lead and Learn" Boehringer Ingelheim Korea announced a plan for expanding domestic clinical studies as one of the global clinical study projects.

Under the guideline of "Lead and Learn", the company motivates the mem...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK